Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:58:05 EDT Sat 18 May 2024
Enter Symbol
or Name
USA
CA



News for U:BHC from 2023-05-18 to 2024-05-17 - 63 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-17 08:01U:BHCNews ReleaseSalix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024
2024-05-15 08:11U:BHCNews ReleaseBausch Health Announces 2024 Annual Meeting of Shareholder Results
2024-05-14 17:39U:BHCNews ReleaseBausch Health Announces Updates Related to Norwich XIFAXAN Matters
2024-05-14 16:24U:BHCNews ReleaseBausch Health Announces Updates Related to Norwich XIFAXAN Matters
2024-05-09 08:05U:BHCNews ReleaseSalix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
2024-05-02 07:03U:BHCNews ReleaseBausch Health Announces First Quarter 2024 Results
2024-04-11 16:23U:BHCNews ReleaseBausch Health to Announce First-Quarter 2024 Results on May 2
2024-04-11 13:06U:BHCNews ReleaseCourt of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029
2024-04-11 08:02U:BHCNews ReleaseAcne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
2024-04-05 18:16U:BHCNews ReleaseBausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
2024-04-03 08:03U:BHCNews ReleaseBausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults
2024-04-02 08:04U:BHCNews ReleaseBased on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations
2024-03-06 08:03U:BHCNews ReleaseSalix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma
2024-03-05 08:03U:BHCNews ReleaseNew Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure
2024-03-01 08:04U:BHCNews ReleaseBausch Health Companies to Present at Cowen Annual Health Care Conference
2024-02-22 07:06U:BHCNews ReleaseBausch Health Announces Fourth-Quarter and Full-Year 2023 Results
2024-02-12 08:04U:BHCNews ReleaseSalix Announces 2024 Gastrointestinal Health Scholars Program
2024-02-01 16:13U:BHCNews ReleaseBausch Health Announces Board Refreshment
2024-02-01 08:01U:BHCNews ReleaseBausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22
2024-01-30 08:04U:BHCNews ReleaseCABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S.
2024-01-18 16:51U:BHCNews ReleaseCORRECTION BY SOURCE: Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
2024-01-18 08:03U:BHCNews ReleaseSolta Medical ¢ € ™s Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
2024-01-08 11:17U:BHCNews ReleaseCourt of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute
2023-12-21 07:02U:BHCNews ReleaseBausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis
2023-12-18 08:02U:BHCNews ReleaseDUOBRII(TM) Lotion to Treat Moderate to Severe Plaque Psoriasis Now Available Through Quebec ¢ € ™s Public Drug Plan
2023-12-05 08:03U:BHCNews ReleaseSalix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day
2023-11-10 12:43U:BHCNews ReleaseCORRECTION BY SOURCE: The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
2023-11-10 08:02U:BHCNews ReleaseThe Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
2023-11-08 08:02U:BHCNews ReleaseAs Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)
2023-11-02 08:21U:BHCNews ReleaseBausch Health Announces Third-Quarter 2023 Results
2023-11-02 08:19U:BHCNews ReleaseBausch Health Announces Third-Quarter 2023 Results
2023-11-01 12:23U:BHCNews ReleaseU.S. District Court Dismisses Norwich's Lawsuit Against the FDA
2023-10-26 08:03U:BHCNews ReleaseBausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder (SAD)
2023-10-20 17:21U:BHCNews ReleaseFDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older
2023-10-17 08:02U:BHCNews ReleaseNew Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence
2023-10-12 08:02U:BHCNews ReleaseBausch Health to Announce Third-Quarter 2023 Results on Nov. 2
2023-10-10 08:04U:BHCNews ReleaseSalix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase in Chronic Liver Disease and Cirrhosis-Related Deaths Marking These as Ninth Leading Cause of Death in U.S.
2023-10-04 08:02U:BHCNews ReleaseSalix Pharmaceuticals Partners with Bellamy Young
2023-09-29 10:17U:BHCNews ReleaseBausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R)
2023-09-24 02:01U:BHCNews ReleaseBHC FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action - BHC
2023-09-21 08:03U:BHCNews ReleaseLeague of United Latin American Citizens (LULAC) Joins OraPharma in the Fight Against Gum Disease
2023-09-18 18:01U:BHCNews ReleaseROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Bausch Health Companies Inc. Investors with Losses to Secure Counsel Before Important September 25 Deadline in Securities Class Action - BHC
2023-09-18 17:50U:BHCNews ReleaseBausch Health Announces CFO Transition Plan
2023-09-16 14:01U:BHCNews ReleaseROSEN, TRUSTED INVESTOR COUNSEL, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action - BHC
2023-09-12 08:02U:BHCNews ReleaseNew Bausch Health Treatment PrUCERIS(R) (budesonide) Aerosol Foam Now Available Across Canada to Treat Mild to Moderate Distal Ulcerative Colitis in Adults
2023-09-12 03:31U:BHCNews ReleaseROSEN, A TOP RANKED LAW FIRM, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action - BHC
2023-09-11 08:01U:BHCNews ReleaseBausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R)
2023-09-06 18:18U:BHCNews ReleaseBausch Health's Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA(R)
2023-09-04 23:31U:BHCNews ReleaseROSEN, A RESPECTED AND LEADING FIRM, Encourages Bausch Health Companies Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BHC
2023-09-02 19:01U:BHCNews ReleaseROSEN, A LEADING LAW FIRM, Encourages Bausch Health Companies Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BHC
2023-08-14 02:01U:BHCNews ReleaseROSEN, A TOP RANKED LAW FIRM, Encourages Bausch Health Companies Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BHC
2023-08-12 15:01U:BHCNews ReleaseROSEN, A LEADING NATIONAL FIRM, Encourages Bausch Health Companies Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BHC
2023-08-03 07:01U:BHCNews ReleaseBausch Health Announces Second-Quarter 2023 Results, Other Key Updates From the Quarter, and Raises Full-Year 2023 Revenue Outlook
2023-07-27 08:00U:BHCNews ReleaseOrtho Dermatologics Announces 2023 Aspire Higher Scholarship Recipients
2023-07-13 08:01U:BHCNews ReleaseBausch Health to Announce Second-Quarter 2023 Results on Aug. 3
2023-07-11 08:02U:BHCNews ReleaseSalix Announces 2023 Gastrointestinal Health Scholars Program Winners
2023-07-07 08:01U:BHCNews ReleaseOraPharma to Participate in the First-Ever Research and Technology Pavilion Sponsored by Pacific Dental Services(R) at the American Dental Hygienists' Association (ADHA(R)) Annual Conference
2023-07-07 07:01U:BHCNews ReleaseBausch Health Enters Into $600 Million Financing Facility With KKR
2023-06-30 08:32U:BHCNews ReleaseBausch Health ¢ € ™s Bausch + Lomb to Acquire Novartis ¢ € ™ XIIDRA(R)
2023-06-19 08:01U:BHCNews ReleaseSalix to Present Data from XIFAXAN(R) (Rifaximin) Clinical Research at EASL's International Liver Congress(TM) 2023
2023-06-06 08:01U:BHCNews ReleaseBausch Health Responds to Norwich's ANDA Tentative Approval and Lawsuit Against United States Food and Drug Administration
2023-05-31 08:00U:BHCNews ReleaseOraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease
2023-05-18 08:27U:BHCNews ReleaseNew Clinical Study Suggests the Use of OraPharma ¢ € ™s ARESTIN(R) (minocycline HCl) Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis